Core Insights - Liansheng Chemical (301212.SZ) reported a total operating revenue of 343 million yuan for the first half of 2025, an increase of 41.98 million yuan or 13.95% compared to the same period last year [1] - The net profit attributable to shareholders was 18.02 million yuan, up by 1.58 million yuan or 9.61% year-on-year [1] Financial Performance - The company achieved a net cash inflow from operating activities of 50.66 million yuan, ranking 51st among disclosed peers, with an increase of 160 million yuan compared to the same period last year [1] - The latest debt-to-asset ratio is 19.04%, ranking 31st among peers, with a decrease of 0.22 percentage points from the previous quarter [3] - The gross profit margin is 12.67%, up by 0.05 percentage points, marking two consecutive quarters of increase [3] - Return on equity (ROE) stands at 1.33%, an increase of 0.10 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.17 yuan, an increase of 0.02 yuan or 13.33% compared to the same period last year [3] - The total asset turnover ratio is 0.20 times, an increase of 0.02 times or 11.92% year-on-year [3] - The inventory turnover ratio is 3.13 times, ranking 34th among peers, with an increase of 0.95 times or 43.53% year-on-year [3] Shareholder Structure - The number of shareholders is 8,697, with the top ten shareholders holding 83.76 million shares, accounting for 77.56% of the total share capital [3] - The largest shareholder is Liansheng Chemical Group Co., Ltd., holding 52.7% of the shares [3]
联盛化学(301212.SZ)：2025年中报净利润为1802.17万元、较去年同期上涨9.61%